Industry Segment and Operations by Geographic Areas

6 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

Industry Segment and Operations by Geographic Areas

5. Industry Segment and Operations by Geographic Areas

The Company has one operating segment, drug delivery, which includes the development of injection devices and injection based pharmaceutical products as well as transdermal gel products.

Revenues by customer location are summarized as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2013		2012		2013		2012
United States of America	$	5,145,676	$	2,991,985	$	8,672,963	$	8,202,153
Europe		604,268		1,489,520		1,537,907		2,660,753
Other		87,600		42,437		154,896		525,578
	$	5,837,544	$	4,523,942	$	10,365,766	$	11,388,484

Revenues by product type:

	Three Months Ended June 30,				Six Months Ended June 30,
	2013		2012		2013		2012
Injection devices and supplies	$	5,346,220	$	3,320,607	$	8,782,720	$	5,904,944
Transdermal products		491,324		1,203,335		1,583,046		5,483,540

Significant customers comprising 10% or more of total revenue are as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2013		2012		2013		2012
Teva	$	4,736,762	$	1,795,057	$	7,192,028	$	3,168,485
Ferring		529,943		1,489,520		1,463,582		2,660,753
Actavis (Watson)		224,788		1,025,976		1,099,116		4,687,855